Drug elution without the need for stent struts and polymers: A promising technology?

Interventional Cardiology (London)

Volumn 4, Issue 3, 2012, Pages 291-295

  Latib, Azeem ^a   Basavarajaiah, Sandeep ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

de novo lesion; drug eluting balloon; instent restenosis; paclitaxel

Indexed keywords

ANTITHROMBOCYTIC AGENT; EXCIPIENT; PACLITAXEL; POLYMER; RAPAMYCIN;

ARTERY DIAMETER; BALLOON; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY DISEASE; CORONARY BIFURCATION LESION; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG ELUTING BALLOON; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

EID: 84864182370     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.12.26     Document Type: Review

References (25)

1. Simpfendorfer C, Belardi J, Bellamy G et al. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 59, 267-269 (1987).
2. Gaul G, Hollman J, Simpfendorfer C, Franco I. Acute occlusion in multiple lesion coronary angioplasty: Frequency and management. J. Am. Coll. Cardiol. 13, 283-288 (1989).
3. Stettler C, Wandel S, Allemann S et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 370(9591), 937-948 (2007).
4. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17), 2126-2130 (2005).
5. Mathew V, Gersh BJ, Williams BA et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: A report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109, 476-480 (2004).
6. Kastrati A, Dibra A, Mehilli J et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113, 2293-2300 (2006).
7. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 110, 810-814 (2004).
8. Herdeg C, Oberhoff M, Baumbach A et al. Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J. Am. Coll. Cardiol. 35, 1969-1976 (2000).
9. Speck U, Scheller B, Abramjuk C et al. Neointima inhibition: Comparison of effectiveness of nonstent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240, 411-418 (2006).
10. Albrecht T, Speck U, Baier C, Wolf KJ, Bohm M, Scheller B. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest. Radiol. 42, 579-585 (2007).
11. Scheller B, Kuhler M, Cremers B, Mahnkopf D, Bohm M, Boxberger M. Short-and long-term effects of a novel paclitaxel coated stent in the porcine coronary model. Clin. Res. Cardiol. 97, 118-123 (2008).
12. Latib A, Mussardo M, Ielasi A et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc. Interv. 4(2), 155-164 (2011).
13. Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. 355, 2113-2124 (2006).
14. Scheller B, Hehrlein C, Bocksch W et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 97, 773-781 (2008).
15. Scheller B, Clever YP, Kelsch B et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc. Interv. 5(3), 323-330 (2012).
16. Unverdorben M, Vallbracht C, Cremers B et al. paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119, 2986-2994 (2009).
17. Habara S, Mitsudo K, Kadota K et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc. Interv. 4(2), 149-154 (2011).
18. Rittger H, Brachmann J, Sinha AM et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES Study. J. Am. Coll. Cardiol. 59(15), 1377-1382 (2012).
19. Stella PR, Belkacemi A, Waksman R et al. The Valentines trial: Results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention 7(6), 705-710 (2011).
20. Unverdorben M, Kleber FX, Heuer H et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 99, 165-174 (2010).
21. Cortese B, Micheli A, Picchi A et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96, 1291-1296 (2010).
22. Hamm CW, Cremers B, Moellmann H et al. Paclitaxel-eluting PTCA-balloon in combination with the coroflex blue stent (CoroflexDEBlue system) vs the sirolimus coated cypher stent in the treatment of advanced coronary artery disease. Circulation 120, 2152-2161 (2009).
23. Colombo A, Latib A, Carlino M et al. A multicentre randomized study of the paclitaxel drug-eluting balloon to reduce restenosis in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study: Late breaking clinical trial session. Presented at: JOINT Interventional Meeting 2012. Rome, Italy, 9-11 February 2012.
24. Ali RM, Degenhardt R, Zambahari R et al. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7(Suppl. K), K83-K92 (2011).
25. Stella P, Belkacemi A, Dubois C et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc. Interv. doi:10.1002/ ccd.23499 (2012) (Epub ahead of print).